project id: TCGA-BRCA; case submitter id: TCGA-AN-A0XR; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.4; rna integrity number: 7.4; spectrophotometer method: UV Spec; age at index: 55; days to birth: -20381; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1955; age at diagnosis: 20381; ajcc pathologic m: M0; ajcc pathologic n: N2; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T2; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 10.0; icd 10 code: C50.9; last known disease status: not reported; morphology: 8500/3; primary diagnosis: Infiltrating duct carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Breast, NOS; synchronous malignancy: No; tissue or organ of origin: Breast, NOS; tumor grade: Not Reported; year of diagnosis: 2010; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 155; initial weight: 130.0; sample id: 6edcdb8a-80e8-42a8-86ff-3950c1f3cb89; sample submitter id: TCGA-AN-A0XR-01A; portion id: 766b03b9-8a5e-4e2e-8833-4e853bab02d8; portion submitter id: TCGA-AN-A0XR-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 1.0; percent normal cells: 0.0;